Clinical trial
Impact of Nociceptive-Level (NOL) Intraoperative Guided Fentanyl Analgesia Versus Standard Clinical Care (SCC) for Elective Major Abdominal Surgery
NCT03970291 is registered in ClinicalTrials.gov with Medasense Biometrics Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Nociceptive-Level (NOL) Intraoperative Guided Fentanyl Analgesia Versus Standard Clinical Care (SCC) for Elective Major Abdominal Surgery
- Lead sponsor
- Medasense Biometrics Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2019
- Completion date
- June 30, 2021
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia